Australia's Immuron hits near 1.5-month high on distribution deal in US
BUZZ-Australia's Immuron hits near 1.5-month high on distribution deal in US ** Shares of Australia's Immuron IMC.AX soar as much as 18.9% to A$0.044, their highest since July 20
** Stock set for its biggest gain since August 26
** The biopharmaceutical company enters into an exclusive distribution agreement for digestive health product PROIBS in the U.S. with Swedish life science firm Calmino group AB
** Nearly 935,000 shares change hands, around 8.1x 30-day average
** YTD, stock up 11.1%
(Reporting by Tejas Harish in Bengaluru)
Recent news on Immuron
See all newsBrief: Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
Australia's Immuron hits near 1.5-month high on distribution deal in US
Brief: Immuron Executes Exclusive Distribution Agreement For Proibs In The United States
Brief: Immuron Reports FY26 Preliminary Results
Brief: Immuron Posts FY Revenue From Ordinary Activities Of A$7.71 Million